{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,20]],"date-time":"2026-09-20T14:16:16Z","timestamp":1789913776168,"version":"4.0.1"},"reference-count":32,"publisher":"Pharmaceutical Society of Japan","issue":"7","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biological & Pharmaceutical Bulletin","Biol. Pharm. Bull."],"published-print":{"date-parts":[[2017]]},"DOI":"10.1248\/bpb.b17-00137","type":"journal-article","created":{"date-parts":[[2017,6,30]],"date-time":"2017-06-30T18:06:21Z","timestamp":1498845981000},"page":"1055-1062","source":"Crossref","is-referenced-by-count":15,"title":["A Nanoparticle-Based Ophthalmic Formulation of Dexamethasone Enhances Corneal Permeability of the Drug and Prolongs Its Corneal Residence Time"],"prefix":"10.1248","volume":"40","author":[{"given":"Noriaki","family":"Nagai","sequence":"first","affiliation":[{"name":"Faculty of Pharmacy, Kindai University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yosuke","family":"Nakazawa","sequence":"additional","affiliation":[{"name":"Faculty of Pharmacy, Keio University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshimasa","family":"Ito","sequence":"additional","affiliation":[{"name":"Faculty of Pharmacy, Kindai University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazutaka","family":"Kanai","sequence":"additional","affiliation":[{"name":"Department of Small Animal Internal Medicine, School of Veterinary Medicine, University of Kitasato"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Norio","family":"Okamoto","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Kindai University, Faculty of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshikazu","family":"Shimomura","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Kindai University, Faculty of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"163","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1) Munoz-Fernandez S, Martin-Mola E. Uveitis. Best Pract. Res. Clin. Rheumatol.<\/i>, 20<\/b>, 487\u2013505 (2006).","DOI":"10.1016\/j.berh.2006.03.008"},{"key":"2","unstructured":"2) Kristinsson JK, Fridriksdottir H, Thorisdottir S, Sigurdardottir AM, Stefansson E, Loftsson T. Dexamethasone\u2013cyclodextrinpolymer co-complexes in aqueous eye drops. Aqueous humor pharmacokinetics in humans. Invest. Ophthalmol. Vis. Sci.<\/i>, 37<\/b>, 1199\u20131203 (1996)."},{"key":"3","unstructured":"3) Leibowitz HM, Kupferman A. Bioavailability and therapeutic effectiveness of topically administered corticosteroids. Trans. Am. Acad. Ophthalmol. Otol.<\/i>, 79<\/b>, 78\u201388 (1975)."},{"key":"4","unstructured":"4) Lee VHL, Robinson JR. Topical ocular drug delivery: Recent developments and future challenges. J. Ocul. Pharmacol.<\/i>, 2<\/b>, 67\u2013108 (1986)."},{"key":"5","doi-asserted-by":"crossref","unstructured":"5) Lee VHL. New directions in the optimization of ocular drug delivery. J. Ocul. Pharmacol.<\/i>, 6<\/b>, 157\u2013164 (1990).","DOI":"10.1089\/jop.1990.6.157"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6) Gupta H, Aqil M, Khar RK, Ali A, Bhatnagar A, Mittal G. Biodegradable levofloxacin nanoparticles for sustained ocular drug delivery. J. Drug Target.<\/i>, 19<\/b>, 409\u2013417 (2011).","DOI":"10.3109\/1061186X.2010.504268"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7) Li X, Zhang Z, Li J, Sun S, Weng Y, Chen H. Diclofenac\/biodegradable polymer micelles for ocular applications. Nanoscale<\/i>, 4<\/b>, 4667\u20134673 (2012).","DOI":"10.1039\/c2nr30924f"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8) Diebold Y, Jarrin M, Saez V, Carvalho ELS, Orea M, Calonge M, Seijo B, Alonso MJ. Ocular drug delivery by liposome\u2013chitosan nanoparticle complexes (LCS-NP). Biomaterials<\/i>, 28<\/b>, 1553\u20131564 (2007).","DOI":"10.1016\/j.biomaterials.2006.11.028"},{"key":"9","unstructured":"9) Sultana Y, Aqil M, Ali A. Ion-activated, Gelrite\u00ae<\/sup>-based in situ<\/i> ophthalmic gels of pefloxacin mesylate: comparison with conventional eye drops. Drug Deliv.<\/i>, 13<\/b>, 215\u2013219 (2006)."},{"key":"10","doi-asserted-by":"crossref","unstructured":"10) El-Kamel AH. In vitro<\/i> and in vivo<\/i> evaluation of Pluronic F127-based ocular delivery system for timolol maleate. Int. J. Pharm.<\/i>, 241<\/b>, 47\u201355 (2002).","DOI":"10.1016\/S0378-5173(02)00234-X"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11) Casolaro M, Casolaro I, Lamponi S. Stimuli-responsive hydrogels for controlled pilocarpine ocular delivery. Eur. J. Pharm. Biopharm.<\/i>, 80<\/b>, 553\u2013561 (2012).","DOI":"10.1016\/j.ejpb.2011.11.013"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12) Asasutjarit R, Thanasanchokpibull S, Fuongfuchat A, Veeranondha S. Optimization and evaluation of thermoresponsive diclofenac sodium ophthalmic in situ<\/i> gels. Int. J. Pharm.<\/i>, 411<\/b>, 128\u2013135 (2011).","DOI":"10.1016\/j.ijpharm.2011.03.054"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13) Davies NM, Fair SJ, Hadgraft J, Kellaway IW. Evaluation of mucoadhesive polymers in ocular drug delivery. I Viscous solutions. Pharm. Res.<\/i>, 8<\/b>, 1039\u20131043 (1991).","DOI":"10.1023\/A:1015813225804"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14) Rafie F, Javadzadeh Y, Javadzadeh AR, Ghavidel LA, Jafari B, Moogooee M, Davaran S. In vivo<\/i> evaluation of novel nanoparticles containing dexa-methasone for ocular drug delivery on rabbit eye. Curr. Eye Res.<\/i>, 35<\/b>, 1081\u20131089 (2010).","DOI":"10.3109\/02713683.2010.508867"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15) Cohen S, Yoshioka T, Lucarelli M, Hwang LH, Langer R. Controlled delivery systems for proteins based on poly(lactic\/glycolic acid) microspheres. Pharm. Res.<\/i>, 8<\/b>, 713\u2013720 (1991).","DOI":"10.1023\/A:1015841715384"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16) Tomoda K, Terashima H, Suzuki K, Inagi T, Terada H, Makino K. Enhanced transdermal delivery of indomethacin-loaded PLGA nanoparticles by iontophoresis. Colloids Surf. B Biointerfaces<\/i>, 88<\/b>, 706\u2013710 (2011).","DOI":"10.1016\/j.colsurfb.2011.08.004"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17) Tomoda K, Terashima H, Suzuki K, Inagi T, Terada H, Makino K. Enhanced transdermal delivery of indomethacin using combination of PLGA nanoparticles and iontophoresis in vivo<\/i>. Colloids Surf. B Biointerfaces<\/i>, 92<\/b>, 50\u201354 (2012).","DOI":"10.1016\/j.colsurfb.2011.11.016"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18) Tomoda K, Watanabe A, Suzuki K, Inagi T, Terada H, Makino K. Enhanced transdermal permeability of estradiol using combination of PLGA nanoparticles system and iontophoresis. Colloids Surf. B Biointerfaces<\/i>, 97<\/b>, 84\u201389 (2012).","DOI":"10.1016\/j.colsurfb.2012.04.002"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19) Nagai N, Yoshioka C, Ito Y. Topical Therapies for rheumatoid arthritis by gel ointments containing indomethacin nanoparticles in adjuvant-induced arthritis rat. J. Oleo Sci.<\/i>, 64<\/b>, 337\u2013346 (2015).","DOI":"10.5650\/jos.ess14170"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20) Nagai N, Yoshioka C, Mano Y, Tanabe W, Ito Y, Okamoto N, Shimomura Y. A nanoparticle formulation of disulfiram prolongs corneal residence time of the drug and reduces intraocular pressure. Exp. Eye Res.<\/i>, 132<\/b>, 115\u2013123 (2015).","DOI":"10.1016\/j.exer.2015.01.022"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21) Nagai N, Ito Y. A new preparation method for ophthalmic drug nanoparticles. Pharm. Anal. Acta<\/i>, 5<\/b>, 6 (2014). doi: 10.4172\/2153-2435.1000305","DOI":"10.4172\/2153-2435.1000305"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22) Nagai N, Ito Y, Okamoto N, Shimomura Y. A nanoparticle formulation reduces the corneal toxicity of indomethacin eye drops and enhances its corneal permeability. Toxicology<\/i>, 319<\/b>, 53\u201362 (2014).","DOI":"10.1016\/j.tox.2014.02.012"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23) Nagai N, Ono H, Hashino M, Ito Y, Okamoto N, Shimomura Y. Improved corneal toxicity and permeability of tranilast by the preparation of ophthalmic formulations containing its nanoparticles. J. Oleo Sci.<\/i>, 63<\/b>, 177\u2013186 (2014).","DOI":"10.5650\/jos.ess13082"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24) Nagai N, Ito Y. Effect of solid nanoparticle of indomethacin on therapy for rheumatoid arthritis in adjuvant-induced arthritis rat. Biol. Pharm. Bull.<\/i>, 37<\/b>, 1109\u20131118 (2014).","DOI":"10.1248\/bpb.b13-00917"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25) Nagai N, Ito Y. Therapeutic effects of gel ointments containing tranilast nanoparticles on paw edema in adjuvant-induced arthritis rats. Biol. Pharm. Bull.<\/i>, 37<\/b>, 96\u2013104 (2014).","DOI":"10.1248\/bpb.b13-00630"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26) Baba K, Tanaka Y, Kubota A, Kasai H, Yokokura S, Nakanishi H, Nishida K. A method for enhancing the ocular penetration of eye drops using nanoparticles of hydrolysable dye. J. Control. Release<\/i>, 153<\/b>, 278\u2013287 (2011).","DOI":"10.1016\/j.jconrel.2011.04.019"},{"key":"27","unstructured":"27) Wells MR, Kraus K, Batter DK, Blunt DG, Weremowitz J, Lynch SE, Anoniades HN, Hansson HA. Gel matrix vehicles for growth factor application in nerve gap injuries repaired with tubes: a comparison of biomatrix, collagen, and methylcellulose. Exp. Neurol.<\/i>, 146<\/b>, 395\u2013402 (1997)."},{"key":"28","doi-asserted-by":"crossref","unstructured":"28) Tate MC, Shear DA, Hoffman SW, Stein DG, LaPlaca MC. Biocompatibility of methylcellulose-based constructs designed for intracerebral gelation following experimental traumatic brain injury. Biomaterials<\/i>, 22<\/b>, 1113\u20131123 (2001).","DOI":"10.1016\/S0142-9612(00)00348-3"},{"key":"29","doi-asserted-by":"crossref","unstructured":"29) Gupta D, Tator CH, Shoichet MS. Fast-gelling injectable blend of hyaluronan and methylcellulose for intrathecal, localized delivery to the injured spinal cord. Biomaterials<\/i>, 27<\/b>, 2370\u20132379 (2006).","DOI":"10.1016\/j.biomaterials.2005.11.015"},{"key":"30","unstructured":"30) Rolando M, Brezzo G, Giordano P, Campagna P, Burlando S, Calabria G. The Lacrimal System<\/i> (Van Bijsterweld OP, Lemp MA, Spinelli D ed.) Kagler & Ghedini, Amsterdam, pp. 89\u201391 (1991)."},{"key":"31","unstructured":"31) Debbasch C, Pisella PJ, De Saint Jean M, Rat P, Warnet JM, Baudouin C. Mitochondrial activity and glutathione injury in apoptosis induced by unpreserved and preserved beta-blockers on Chang conjunctival cells. Invest. Ophthalmol. Vis. Sci.<\/i>, 42<\/b>, 2525\u20132533 (2001)."},{"key":"32","doi-asserted-by":"crossref","unstructured":"32) Diebold Y, Calonge M. Applications of nanoparticles in ophthalmology. Prog. Retin. Eye Res.<\/i>, 29<\/b>, 596\u2013609 (2010).","DOI":"10.1016\/j.preteyeres.2010.08.002"}],"container-title":["Biological & Pharmaceutical Bulletin","Biological and Pharmaceutical Bulletin"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/bpb\/40\/7\/40_b17-00137\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,27]],"date-time":"2019-09-27T22:31:12Z","timestamp":1569623472000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/bpb\/40\/7\/40_b17-00137\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017]]},"references-count":32,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2017]]}},"URL":"https:\/\/doi.org\/10.1248\/bpb.b17-00137","relation":{},"ISSN":["0918-6158","1347-5215"],"issn-type":[{"value":"0918-6158","type":"print"},{"value":"1347-5215","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017]]}}}